touchONCOLOGY were honoured to meet Denis Lacombe, Director General, European Organisation for Research and Treatment of Cancer (EORTC), at the ECCO 2019 European Cancer Summit in Brussels to discuss the latest exciting updates in clinical cancer research across Europe: do we need to change tracks?
1. What are the key recent advances in clinical cancer research in Europe – how will they impact treatments for patients? (0:08)
2. How has the development of anti-cancer treatments changed in recent years and how is it continuing to change? (0:40)
3. Despite recent advances, is the current clinical research in cancer in Europe addressing the right issues or pursuing the right targets? (1:38)
4. What is the European Organisation for Research and Treatment of Cancer (EORTC) doing to address the difficulties in developing new cancer therapies and make them available to patients more quickly? (2:38)
5. Given the ongoing pace of progress of clinical cancer research and treatment developments, do you feel optimistic that the prognosis for many patients with cancer is improving and will it continue to do so into the future? (3:44)
Denis Lacombe has no conflicts of interest to declare in relation to this video.
Filmed in partnership with the European CanCer Organisation at the ECCO 2019 European Cancer Summit in Brussels, Belgium.
Share this Video
Related Videos In Policy
Mark Lawler, European Cancer Summit 2022: The ECO-ASCO Special Network
The impact of the Russian invasion on Ukraine and how this has impacted clinical trials and cancer care in Europe. The Special Network on the Impact of the War in Ukraine on Cancer was established by ECO Board and ASCO soon after the war started, and now has representatives of over 300 organisations. In this […]
Mark Lawler, European Cancer Summit, 2022: What is the European Cancer Pulse?
Professor Mark Lawler (Queen’s University Belfast) summarizes the European Cancer Pulse, an exciting new tool that brings together data from 34 European countries and helps determine cancer care disparities on cancer burden, research spending, prevention efforts, early detection, diagnosis and treatment access, survivorship, impact of social determinants and much more. For more information, click here. […]
Mark Lawler, European Cancer Summit 2022: The European Groundshot
The European Groundshot—addressing Europe’s cancer research challenges: a Lancet Oncology Commission is a unique imitative launched this year aims to identify the challenges in cancer care in Europe. The COVID-19 pandemic has had a significant impact on cancer diagnosis and halted many ongoing clinical trials. In this video, Professor Mark Lawler (Queen’s University Belfast) describes […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!